An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia-Full report-Reference-Cited by-同舟云学术

An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia-Full report

Published:2014-01 Issue:1 Volume:8 Page:29-60
ISSN:1933-2874
Container-title:Journal of Clinical Lipidology
language:en
Short-container-title:Journal of Clinical Lipidology

Author:

Grundy Scott M.,Arai Hidenori,Barter Philip,Bersot Thomas P.,Betteridge D. John,Carmena Rafael,Cuevas Ada,Davidson Michael H.,Genest Jacques,Kesäniemi Y. Antero,Sadikot Shaukat,Santos Raul D.,Susekov Andrey V.,Sy Rody G.,LaleTokgözoglu S.,Watts Gerald F.,Zhao Dong

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference346 articles.

1. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the Pooling Project;J Chronic Dis,1978

2. Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT);Stamler;JAMA,1986

3. Cholesterol and mortality: 30 years of follow-up from the Framingham Study;Anderson;JAMA,1987

4. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?;Law;BMJ,1994

5. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease;JAMA,1984

Cited by 294 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Obicetrapib on top of maximally tolerated lipid‐modifying therapies in participants with or at high risk for atherosclerotic cardiovascular disease: rationale and designs of BROADWAY and BROOKLYN;American Heart Journal;2024-08

2. Lipid-Lowering Medications for Managing Dyslipidemia: A Narrative Review;Cureus;2024-07-23

3. The Diagnosis and Treatment of Lipid Abnormalities in Pediatric Patients;Current Pediatrics Reports;2024-07-18

4. Treat-to-target or high-intensity statin treatment in older adults with coronary artery disease: a post hoc analysis of the LODESTAR trial;Age and Ageing;2024-07

5. Serum Lipoproteins Are Associated With Coronary Atherosclerosis in Asymptomatic U.S. Adults Without Traditional Risk Factors;JACC: Advances;2024-07